The Long View: Bayer Shows Up Early, And On Purpose
Capsul Desk
5 min read
members
Archive
Page 2 of 5
Therapeutic Thursday: Nucleic Acid Drugs Reach For Cardiovascular Mainstream
Capsul Desk
6 min read
members
Watchdog Wednesday: Turning The Clinical Trial Inspection Into A Sales Pitch
Nielsen Hobbs
6 min read
members
Trial Tuesday: MASH, KRAS And Keytruda's Copycat
Manas Mishra
6 min read
members
Milestone Monday: Small Checks, Billion-Dollar Promises
Capsul Desk
4 min read
members
The Long View: Europe Sends A Warning, Japan Sends A Number
Aakash Babu
6 min read
members
Featured
Therapeutic Thursday: The Lab Has A New Tenant
Aakash Babu
5 min read
members
Watchdog Wednesday: When Enforcing Your Patent Becomes A Problem
Nielsen Hobbs
5 min read
members
Featured
Trial Tuesday: R&D Posts Favor AI Muscles, Plus A (Brief?) Lull In China
Manas Mishra
5 min read
members
Milestone Monday: At BIO 2026, The Sellers Set The Pace
Capsul Desk
6 min read
members
The Long View: After 11 Years, 2 Months, 23 Days and One $62bn Deal, Weber Hands Takeda to Kim
Capsul Desk
7 min read
members
Therapeutic Thursday: Psychedelics Are Finally Backing the Hype. Can AI Follow?
Aakash Babu
5 min read
members